European Patent Office to Grant Merck's Patent Application for CRISPR Technology Ruby Khatun Khatun6 Aug 2017 9:30 AM ISTDARMSTADT, Germany: Merck, a leading science and technology company, announced the European Patent Office (EPO) has issued a "Notice of Intention to...
Punjab to examine feasibility of new drug for Hepatitis-C Ruby Khatun Khatun6 Aug 2017 9:30 AM ISTChandigarh: Punjab Chief Minister Captain Amarinder Singh asked the health department to examine the feasibility of a new drug Epclusa for treatment...
Big Pharma plans to turn rural India into a cash cow Ruby Khatun Khatun6 Aug 2017 9:20 AM ISTBy Ari AltstedterFirst, foreign food brands flooded India with chips, cookies and soft drinks that fundamentally changed the nation’s eating habits....
Bristol-Myers Squibb and Clovis Oncology Announce a Broad Clinical Collaboration Ruby Khatun Khatun6 Aug 2017 9:16 AM ISTNew York & Boulder, Colo.: Bristol-Myers Squibb Company and Clovis Oncology, Inc. announced the companies have entered into a clinical...
USFDA to review Teva and Celltrion's cancer biosimilar drug Ruby Khatun Khatun6 Aug 2017 9:15 AM ISTJERUSALEM: Teva Pharmaceutical Industries and South Korea's Celltrion said the U.S. Food and Drug Administration has accepted for review a biologics...
FDA Approves Long-acting Injectable for Bipolar Disorder Ruby Khatun Khatun5 Aug 2017 9:20 AM ISTValby, Denmark and Tokyo, Japan: Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced Abilify Maintena®(aripiprazole) for...
Lupin gets USFDA nod for cholesterol-lowering drug Ruby Khatun Khatun5 Aug 2017 9:18 AM ISTNew Delhi: Drug firm Lupin on Thursday said it has received final approval from the US health regulator to market its Rosuvastatin Calcium tablets...
Biocon Q1 net profit slumps 51 percent to Rs 81 crore Ruby Khatun Khatun5 Aug 2017 9:16 AM ISTNew Delhi: Bio-pharmaceutical firm Biocon reported a 51.20 per cent decline in its consolidated net profit to Rs 81.3 crore for the quarter ended...
AstraZeneca gets breakthrough status for blood cancer drug Ruby Khatun Khatun5 Aug 2017 9:15 AM ISTLONDON: AstraZeneca said that U.S. regulators had awarded its blood cancer drug acalabrutinib "breakthrough" status for the treatment of patients with...
Johnson & Johnson arthritis drug sirukumab raises safety concerns: FDA staff Ruby Khatun Khatun5 Aug 2017 9:15 AM ISTThere were more deaths in patients taking Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab than among those taking a placebo,...
Daiichi Sankyo settles US lawsuits over blood pressure drug Benicar Ruby Khatun Khatun5 Aug 2017 9:14 AM ISTNew York: Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of...
FDA approves new targeted treatment for relapsed or refractory acute myeloid leukemia Ruby Khatun Khatun4 Aug 2017 9:25 AM ISTThe U.S. Food and Drug Administration (FDA) approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory acute myeloid...
